GSA CAPITAL PARTNERS LLP - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 281 filers reported holding ROYALTY PHARMA PLC in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.6%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$1,921
+388.8%
70,791
+454.0%
0.16%
+323.1%
Q2 2023$393
-16.6%
12,779
-2.2%
0.04%
-17.0%
Q1 2023$471
-99.9%
13,069
+1.5%
0.05%
-42.0%
Q2 2022$541,000
+72.8%
12,874
+63.9%
0.08%
+107.7%
Q4 2021$313,000
+2.6%
7,857
+5.6%
0.04%
+14.7%
Q2 2021$305,000
+29.8%
7,440
+58.3%
0.03%
-10.5%
Q4 2020$235,0004,7000.04%
Other shareholders
ROYALTY PHARMA PLC shareholders Q2 2022
NameSharesValueWeighting ↓
Siguler Guff Advisers, LLC 3,391,754$92,052,20447.04%
Indie Asset Partners, LLC 433,000$11,751,62011.84%
SUVRETTA CAPITAL MANAGEMENT, LLC 4,095,745$111,158,5196.01%
Advanced Portfolio Management, LLC 230,000$6,242,2005.25%
Compound Global Advisors, LLC 626,412$17,000,8223.73%
Geo Capital Gestora de Recursos Ltd 135,079$3,6663.39%
TORRAY INVESTMENT PARTNERS LLC 412,633$11,198,8601.98%
Overbrook Management Corp 298,712$8,107,0441.89%
Silicon Valley Community Foundation 358,270$9,723,4481.18%
Greytown Advisors Inc. 74,601$2,024,6711.12%
View complete list of ROYALTY PHARMA PLC shareholders